Dual PD-1 and VEGF Targeting in a Single Treatment
Ivonescimab is a…
Dual-Checkpoint Immunotherapy Combined With First-Line Treatment Instead of blocking only one immune…
A newer treatment strategy for advanced urothelial cancer combines disitamab vedotin, a…
Immunotherapy Combined With Chemotherapy for Recurrent or Metastatic Disease Nasopharyngeal carcinoma is…
Immunotherapy Combined With Chemotherapy for Recurrent or Metastatic Disease Nasopharyngeal carcinoma is…
Combining Immunotherapy With VEGFR-Targeted Therapy For patients with unresectable or metastatic hepatocellular…